Proteome analysis of human cerebrospinal fluid as a diagnostic biomarker in patients with meningioma

Medical Science Monitor

Volumn 18, Issue 11, 2012, Pages

  Kim, Jae Ho ^a   Lee, Sang Kwang ^a   Yoo, Yong Cheol ^a   Park, Nam Hyun ^a,b   Park, Dan Bi ^a,b   Yoo, Jong Shin ^a,b   An, Hyun Joo ^b   Park, Young Mok ^a,b   Cho, Kyung Gi ^c  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b Chungnam National University   (South Korea)

^c CHA University   (South Korea)

Author keywords

Biomarker; Brain tumor; Human cerebrospinal fluid; Meningioma; Proteome

Indexed keywords

ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN E; BETA 2 MICROGLOBULIN; BETA ACTIN; CLUSTERIN; HEMOGLOBIN D; HIGH DENSITY LIPOPROTEIN; PREALBUMIN; PROSTAGLANDIN D2; PROTEINASE; PROTEOME; SERUM ALBUMIN;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONCENTRATION (PARAMETERS); CYTOSKELETON; HUMAN; IMMUNOHISTOCHEMISTRY; MENINGIOMA; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 84868599908     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.883538     Document Type: Article

References (33)

1. Khwaja FW, Reed MS, Olson JJ et al: Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients. J Proteome Res, 2007; 6: 559-70
2. Yuan X, Desiderio DM: Proteomics analysis of human cerebrospinal fluid. J Chromatogr, 2005; 815: 179-89
3. Le Bastard N, Martin JJ, Vanmechelen E et al: Added diagnostic value of CSF biomarkers in differential dementia diagnosis. Neurobiol Aging, 2010; 31(11): 1867-76
4. Tarnaris A, Watkins LD, Kitchen ND: Biomarkers in chronic adult hydrocephalus. Cerebrospinal Fluid Res, 2006; 3: 11
5. Zougman A, Pilch B, Podtelejnikov A et al: Integrated analysis of the cerebrospinal fluid peptidome and proteome. J Proteome Res, 2008; 7: 386-99
6. Khwaja FW, Duke-Cohan JS, Brat DJ, Van Meir EG: Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration. Clin Cancer Res, 2006; 12: 6331-36
7. Roy S, Josephson SA, Fridlyand J et al: Protein biomarker identification in the CSF of patients with CNS lymphoma. J Clin Oncol, 2008; 26: 96-105
8. Iwadate Y, Sakaida T, Hiwasa T et al: Molecular classification and survival prediction in human gliomas based on proteome analysis. Cancer Res, 2004; 64: 2496-501
9. Ko KW, Nam DH, Kong DS et al: Relationship between malignant subtypes of meningioma and clinical outcome. J Clin Neurosci, 2007; 14: 747-53
10. Bruna J, Brell M, Ferrer I et al: Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma. Neuropathology, 2007; 27: 114-20
11. Vankalakunti M, Vasishta RK, Das Radotra B, Khosla VK: MIB-1 immunolabeling: a valuable marker in prediction of benign recurring meningiomas. Neuropathology, 2007; 27: 407-12
12. Wulfkuhle JD, Paweletz CP, Steeg PS et al: Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Adv Exp Med Biol, 2003; 532: 59-68
13. Hanrieder J, Wetterhall M, Enblad P et al: Temporally resolved differential proteomic analysis of human ventricular CSF for monitoring traumatic brain injury biomarker candidates. J Neurosci Methods, 2009; 177: 469-78
14. Porubleva L, Vander Velden K, Kothari S et al: The proteome of maize leaves: use of gene sequences and expressed sequence tag data for identification of proteins with peptide mass fingerprints. Electrophoresis, 2001; 22: 1724-38
15. Nam MH, Heo EJ, Kim JY et al: Proteome analysis of the responses of Panax ginseng C. A. Meyer leaves to high light: use of electrospray ionization quadrupole-time of flight mass spectrometry and expressed sequence tag data. Proteomics, 2003; 3: 2351-67
16. Okamoto H, Li J, Vortmeyer AO et al. Comparative proteomic profiles of meningioma subtypes. Cancer Res, 2006; 66: 10199-204
17. Pan S, Zhu D, Quinn JF et al: A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. Proteomics, 2007; 7: 469-73
18. Shintaku M, Hashimoto K, Okamoto S: Intraventricular meningioma with anaplastic transformation and metastasis via the cerebrospinal fluid. Neuropathology, 2007; 27: 448-52
19. Yuan X, Russell T, Wood G, Desiderio DM: Analysis of the human lumbar cerebrospinal fluid proteome. Electrophoresis, 2002; 23: 1185-96
20. Tendulkar RD, Pai Panandiker AS, Wu S et al: Irradiation of Pediatric High-Grade Spinal Cord Tumors. Int J Radiat Oncol Biol Phys, 2010; 78(5): 1451-56
21. Soga N, Kise H, Arima K, Sugimura Y: Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancer. Int J Clin Oncol, 2010; 15(4): 376-81
22. Jin T, Hu LS, Chang M et al: Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients. Eur J Neurol, 2007; 14: 563-68
23. van der Ham M, de Koning TJ, Lefeber D et al: Liquid chromatographytandem mass spectrometry assay for the quantification of free and total sialic acid in human cerebrospinal fluid. J Chromatogr, 2010; 878(15-16): 1098-102
24. Yuan X, Desiderio DM: Protein identification with Teflon as matrix-assisted laser desorption/ionization sample support. J Mass Spectrom, 2002; 37: 512-24
25. de Bont JM, den Boer ML, Reddingius RE et al: Identification of apolipoprotein A-II in cerebrospinal fluid of pediatric brain tumor patients by protein expression profiling. Clin Chem, 2006; 52: 1501-9
26. Murakami M, Ushio Y, Morino Y et al: Immunohistochemical localization of apolipoprotein E in human glial neoplasms. J Clin Invest, 1988; 82: 177-88
27. Zlokovic BV: Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier. Life Sci, 1996; 59: 1483-97
28. Albrecht S, Bayer TA, Kraus JA, Pietsch T: Transthyretin expression in medulloblastomas and medulloblastoma cell lines. Neuropathol Appl Neurobiol, 1995; 21: 399-409
29. Kawashima M, Suzuki SO, Yamashima T et al: Prostaglandin D synthase (beta-trace) in meningeal hemangiopericytoma. Mod Pathol, 2001; 14: 197-201
30. Nakayama H, Echizen H, Gomi T et al: Urinary lipocalin-type prostaglandin D synthase: a potential marker for early gentamicin-induced renal damage? Ther Drug Monit, 2009; 31: 126-30
31. Yamashima T, Sakuda K, Tohma Y et al: Prostaglandin D synthase (betatrace) in human arachnoid and meningioma cells: roles as a cell marker or in cerebrospinal fluid absorption, tumorigenesis, and calcification process. J Neurosci, 1997; 17: 2376-82
32. Shi C, Zhu Y, Su Y, Chung LW, Cheng T: Beta2-microglobulin: emerging as a promising cancer therapeutic target. Drug Discov Today, 2009; 14: 25-30
33. Shores KS, Udugamasooriya DG, Kodadek T, Knapp DR: Use of peptide analogue diversity library beads for increased depth of proteomic analysis: application to cerebrospinal fluid. J Proteome Res, 2008; 7: 1922-31